Doxercalciferol Injection shortage
To Be Discontinued 3 presentations · 1 manufacturers · first FDA posting 2025-12-10 · last update 2025-12-10
Manufacturers: Sanofi-Aventis U.S. LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/10/2025 Updated 12/10/2025 Discontinued 12/10/2025 |
| Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/10/2025 Updated 12/10/2025 Discontinued 12/10/2025 |
| Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1) | Sanofi-Aventis U.S. LLC | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 12/10/2025 Updated 12/10/2025 Discontinued 12/10/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)